161 related articles for article (PubMed ID: 36417925)
1. Systematic Review and Meta-analysis of Lyme Disease Data and Seropositivity for Borrelia burgdorferi, China, 2005‒2020.
Stark JH; Li X; Zhang JC; Burn L; Valluri SR; Liang J; Pan K; Fletcher MA; Simon R; Jodar L; Gessner BD
Emerg Infect Dis; 2022 Dec; 28(12):2389-2397. PubMed ID: 36417925
[TBL] [Abstract][Full Text] [Related]
2. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey].
Aslan Başbulut E; Gözalan A; Sönmez C; Cöplü N; Körhasan B; Esen B; Akın L; Ertek M
Mikrobiyol Bul; 2012 Apr; 46(2):247-56. PubMed ID: 22639313
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy.
Tomao P; Ciceroni L; D'Ovidio MC; De Rosa M; Vonesch N; Iavicoli S; Signorini S; Ciarrocchi S; Ciufolini MG; Fiorentini C; Papaleo B
Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):457-63. PubMed ID: 15948001
[TBL] [Abstract][Full Text] [Related]
5. Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness.
Sanderson VP; Miller JC; Bamm VV; Tilak M; Lloyd VK; Singh-Ranger G; Wills MKB
PLoS One; 2023; 18(11):e0291382. PubMed ID: 37939060
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Borrelia IgG antibodies among individuals from Eastern Slovakia.
Houžvičková A; Dorko E; Rimárová K; Diabelková J; Drabiščák E
Cent Eur J Public Health; 2022 Jun; 30(Supplement):S16-S21. PubMed ID: 35841220
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and the 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot.
Nilsson I; von Rosen IA
APMIS; 1996 Dec; 104(12):907-14. PubMed ID: 9048870
[TBL] [Abstract][Full Text] [Related]
8. [Studies on epidemiology and etiology of Lyme disease in China].
Zhang ZF; Wan KL; Zhang JS
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Feb; 18(1):8-11. PubMed ID: 9812472
[TBL] [Abstract][Full Text] [Related]
9. Global seroprevalence and sociodemographic characteristics of
Dong Y; Zhou G; Cao W; Xu X; Zhang Y; Ji Z; Yang J; Chen J; Liu M; Fan Y; Kong J; Wen S; Li B; Yue P; Liu A; Bao F
BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35697507
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence, spatial distribution and risk factors of Borrelia burgdorferi sensu lato in Jordan.
Obaidat MM; Alshehabat MA; Hayajneh WA; Roess AA
Comp Immunol Microbiol Infect Dis; 2020 Dec; 73():101559. PubMed ID: 33086189
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
12. [An overlooked disease of tick bites: Lyme disease].
Bulut C; Tufan ZK; Altun S; Altinel E; Kinikli S; Demiröz AP
Mikrobiyol Bul; 2009 Jul; 43(3):487-92. PubMed ID: 19795626
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity of main vector-borne pathogens in dogs across Europe.
Miró G; Wright I; Michael H; Burton W; Hegarty E; Rodón J; Buch J; Pantchev N; von Samson-Himmelstjerna G
Parasit Vectors; 2022 Jun; 15(1):189. PubMed ID: 35668469
[TBL] [Abstract][Full Text] [Related]
14. Lyme disease risk in southern California: abiotic and environmental drivers of Ixodes pacificus (Acari: Ixodidae) density and infection prevalence with Borrelia burgdorferi.
MacDonald AJ; Hyon DW; Brewington JB; O'Connor KE; Swei A; Briggs CJ
Parasit Vectors; 2017 Jan; 10(1):7. PubMed ID: 28057067
[TBL] [Abstract][Full Text] [Related]
15. Mapping the risk distribution of
Che TL; Jiang BG; Xu Q; Zhang YQ; Lv CL; Chen JJ; Tian YJ; Yang Y; Hay SI; Liu W; Fang LQ
Emerg Microbes Infect; 2022 Dec; 11(1):1215-1226. PubMed ID: 35411829
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Borrelia burgdorferi seropositivity in an area endemic for Lyme disease.
Jochimsen E; Sikkink J; Marx JJ
Wis Med J; 1990 Dec; 89(12):677-81. PubMed ID: 2293487
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological studies of Lyme borreliosis and tick-borne encephalitis.
Gustafson R
Scand J Infect Dis Suppl; 1994; 92():1-63. PubMed ID: 8047853
[TBL] [Abstract][Full Text] [Related]
18. Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany.
Coors A; Hassenstein MJ; Krause G; Kerrinnes T; Harries M; Breteler MMB; Castell S
Parasit Vectors; 2022 Jul; 15(1):241. PubMed ID: 35786209
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiological investigation of lyme disease and human granulocytic anaplasmosis among people living in forest areas of eight provinces in China.
Hao Q; Geng Z; Hou XX; Tian Z; Yang XJ; Jiang WJ; Shi Y; Zhan ZF; Li GH; Yu DS; Wang HY; Xu JG; Wan KL
Biomed Environ Sci; 2013 Mar; 26(3):185-9. PubMed ID: 23425801
[TBL] [Abstract][Full Text] [Related]
20. Tick exposure and prevalence of Borrelia burgdorferi antibodies among hunters and other individuals exposed to vector ticks in eastern Poland.
Pańczuk A; Tokarska-Rodak M; Plewik D; Paszkiewicz J
Rocz Panstw Zakl Hig; 2019; 70(2):161-168. PubMed ID: 31215781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
